Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 3/20 | 0.41 |
| ▸ | MEN1 | O00255 | 2/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 2/20 | 0.37 |
| ▸ | FAAH | O00519 | 1/20 | 0.37 |
| ▸ | CA1 | P00915 | 1/20 | 0.37 |
| ▸ | CA2 | P00918 | 1/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.37 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.37 |
| ▸ | HPGD | P15428 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.37 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.37 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.37 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.37 |
| ▸ | HTR2C | P28335 | 1/20 | 0.37 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1918403 | 0.93 | ALOX15 (0.41) | KMT2AMEN1TDP1ALOX15LMNA | |
| SCHEMBL16678671 | 0.84 | ALOX15 (0.40) | KMT2AMEN1TDP1ALOX15LMNA | |
| SCHEMBL27908721 | 0.81 | ALDH1A1 (0.37) | KMT2AMEN1TDP1ALOX15LMNA | |
| SCHEMBL16678672 | 0.79 | ALOX15 (0.37) | KMT2AMEN1TDP1ALOX15LMNA | |
| SCHEMBL16678737 | 0.75 | ALOX15 (0.36) | KMT2AMEN1TDP1ALOX15LMNA | |
| SCHEMBL1917017 | 0.75 | GABRA1 (0.41) | KMT2AALOX15LMNAFAAHCA1 | |
| SCHEMBL15923852 | 0.70 | MAPT (0.44) | KMT2AMEN1TDP1L3MBTL1CYP3A4 | |
| SCHEMBL13698771 | 0.70 | GABRA1 (0.41) | KMT2AMEN1TDP1ALOX15LMNA | |
| SCHEMBL22096053 | 0.69 | DPP4 (0.40) | KMT2AMEN1TDP1ALOX15LMNA | |
| SCHEMBL27908724 | 0.69 | ALDH1A1 (0.34) | KMT2AMEN1TDP1ALOX15LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2999730-B1 | POLYMERIZABLE REACTION MIXTURE FOR PRODUCING EPOXY RESINS, AND THE USE THEREOF | DEUTSCHE INST FUER TEXTIL UND FASERFORSCHUNG DENKENDORF (DE) | 2020-04-15 | — | — | EP | disclosed |
| US-20170218121-A2 | RING-OPENING LAUROLACTAM POLYMERIZATION WITH LATENT INITIATORS | EVONIK DEGUSSA GMBH (DE) | 2017-08-03 | — | — | US | disclosed |
| US-20160137774-A1 | LACTONE POLYMERIZATION WITH LATENT INITIATORS | EVONIK DEGUSSA GMBH (DE) | 2016-05-19 | — | — | US | disclosed |
| EP-2999730-A1 | POLYMERIZABLE REACTION MIXTURE FOR PRODUCING EPOXY RESINS, AND THE USE THEREOF | Deutsche Institute für Textil- und Faserforschung Denkendorf (DE) | 2016-03-30 | — | — | EP | disclosed |
| EP-2951227-A1 | METHOD FOR POLYMERIZING -CAPROLACTAM | Evonik Industries AG (DE) | 2015-12-09 | — | — | EP | disclosed |
| US-20150126696-A1 | POLYMERIZATION USING LATENT INITIATORS | EVONIK INDUSTRIES AG (DE) | 2015-05-07 | — | — | US | disclosed |
| WO-2014118076-A1 | METHOD FOR POLYMERIZING Ε-CAPROLACTAM | EVONIK INDUSTRIES AG (DE) | 2014-08-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160137774-A1 | LACTONE POLYMERIZATION WITH LATENT INITIATORS | HACD2, MCCC2, CWC22 | KMT2A 2087/4885MEN1 2433/4885TDP1 4850/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.